-
Limited Competition: Development and Renovation of Housing, Breeding, and Research Spaces for Existing NIH-supported NHP Colonies (C06 Clinical Trial Not Allowed)
(PAR-21-363)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): March 15, 2022
-
Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed)
(PAR-22-057)
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
Office of Research on Women's Health
Application Receipt Date(s): January 20, 2022
-
High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)
(PAR-22-079)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
Application Receipt Date(s): Multiple dates, see announcement.
-
Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
(PAR-22-080)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
Application Receipt Date(s): Multiple dates, see announcement.
-
Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)
(PAR-22-081)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
Application Receipt Date(s): Multiple dates, see announcement.
-
Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
(PAR-22-088)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): March 25, 2022
-
NIA Renewal and Competing Revision Cooperative Agreements in Aging Research (U01 Clinical Trial Optional)
(PAR-22-362)
National Institute on Aging
Application Receipt Date(s): Not Applicable
-
Coordinating Center for the Claude D. Pepper Older Americans Independence Centers (OAICs) (U24 Clinical Trial Optional)
(RFA-AG-23-006)
National Institute on Aging
Application Receipt Date(s): May 16, 2022
-
Pharmacokinetic and Pharmacodynamic (PK/PD) Studies of mTOR Inhibitors on Aging-Related Indications (U01 Clinical Trial Required)
(RFA-AG-23-008)
National Institute on Aging
Application Receipt Date(s): June 15, 2022
-
Host Immunity and Novel Immunization Strategies for Clostridioides difficile Infection (CDI) (U19 Clinical Trial Not Allowed)
(RFA-AI-22-001)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): May 20, 2022
-
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
(RFA-CA-22-005)
National Cancer Institute
Application Receipt Date(s): September 22, 2022
-
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
(RFA-CA-22-006)
National Cancer Institute
Application Receipt Date(s): September 22, 2022
-
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)
(RFA-CA-22-007)
National Cancer Institute
Application Receipt Date(s): September 22, 2022
-
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)
(RFA-CA-22-008)
National Cancer Institute
Application Receipt Date(s): September 22, 2022
-
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
(RFA-CA-22-009)
National Cancer Institute
Application Receipt Date(s): September 22, 2022
-
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
(RFA-CA-22-010)
National Cancer Institute
Application Receipt Date(s): September 22, 2022
-
U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trial Optional)
(RFA-CA-22-011)
National Cancer Institute
John E. Fogarty International Center
Application Receipt Date(s): March 30, 2022
-
HEAL Initiative: HEAL Data2Action Modeling and Economic Resource Center (U24 Clinical Trial Optional)
(RFA-DA-22-049)
National Institute on Drug Abuse
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Center for Complementary and Integrative Health
Application Receipt Date(s): March 10, 2022
-
HEAL Initiative: HEAL Data2Action Research Adoption Support Center (U2C Clinical Trial Optional)
(RFA-DA-22-050)
National Institute on Drug Abuse
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Center for Complementary and Integrative Health
Application Receipt Date(s): March 25, 2022
-
HEAL Initiative: HEAL Data2Action Innovation Projects (R61/R33 Clinical Trial Optional)
(RFA-DA-22-051)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
Application Receipt Date(s): March 10, 2022
-
HEAL Initiative: HEAL Data2Action (HD2A) Data Infrastructure Support Center (U24 Clinical Trial Optional)
(RFA-DA-22-052)
National Institute on Drug Abuse
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Center for Complementary and Integrative Health
Application Receipt Date(s): March 10, 2022
-
Elucidating the heterogeneity of impaired awareness of hypoglycemia in Type 1 Diabetes (T1D) Clinical Centers (U01 Clinical Trial Required)
(RFA-DK-21-020)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): March 31, 2022
-
Elucidating the heterogeneity of impaired awareness of hypoglycemia in Type 1 Diabetes (T1D) - Biostatistics Research Center (U01 Clinical Trial Not Allowed)
(RFA-DK-21-036)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): March 31, 2022
-
Maintaining and Enriching Environmental Epidemiology Cohorts to Support Scientific and Workforce Diversity (U24 Clinical Trial Not Allowed)
(RFA-ES-22-001)
National Institute of Environmental Health Sciences
Application Receipt Date(s): November 3, 2022
-
Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional)
(RFA-HL-23-003)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): March 28, 2024
-
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
(RFA-MD-22-003)
National Institute on Minority Health and Health Disparities
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
Application Receipt Date(s): April 04, 2022
-
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
(RFA-MD-22-004)
National Institute on Minority Health and Health Disparities
National Institute on Aging
National Institute on Drug Abuse
National Institute of Diabetes and Digestive and Kidney Diseases
National Heart, Lung, and Blood Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Institute of Biomedical Imaging and Bioengineering
National Center for Advancing Translational Sciences
Application Receipt Date(s): April 04, 2022
-
Advancing communication strategies to support future HIV vaccine use (R01 Clinical Trial Optional)
(RFA-MH-22-170)
National Institute of Mental Health
National Institute on Drug Abuse
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): May 10, 2022
-
Advancing communication strategies to support future HIV vaccine use (R21 Clinical Trial Optional)
(RFA-MH-22-171)
National Institute of Mental Health
National Institute on Drug Abuse
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): May 10, 2022
-
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection - Testing Laboratories (U01 Clinical Trial Not Allowed)
(RFA-NS-22-003)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): March 14, 2022
-
Limited Competition: Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection - Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-NS-22-004)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): March 14, 2022
-
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies For Acute Cerebroprotection- Interventions (U01 Clinical Trial Not Allowed)
(RFA-NS-22-032)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): March 14, 2022
-
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection- Interventions from Small Businesses (U44 Clinical Trial Not Allowed)
(RFA-NS-22-033)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): March 14, 2022
-
HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
(RFA-NS-22-034)
National Institute of Neurological Disorders and Stroke
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Center for Advancing Translational Sciences
Application Receipt Date(s): Multiple dates, see announcement.